Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-128506
Filing Date
2021-10-21
Accepted
2021-10-21 16:48:20
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2130533-4_424b5.htm 424B5 1220437
2 GRAPHIC lg_ivericbio-4clr.jpg GRAPHIC 13471
  Complete submission text file 0001104659-21-128506.txt   1240201
Mailing Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

EIN.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-260406 | Film No.: 211337501
SIC: 2834 Pharmaceutical Preparations